Bausch Health Companies Inc. has grown revenue 9.1% a year over three years and 5.1% a year over five. Revenue growth, 3-year annual rate: +9.1% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +5.1%, growth has picked up over the last three years. Years of annual history on file: 18, FY2008 to FY2025, as filed.

BHCBausch Health Companies Inc.

Healthcare

$6.04-10% 1Y

$6.04

$4.4452 weeks$7.90

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +10% year on year, but operating margin narrowing (−9.0 points).

1 good, 1 to watch, 1 without data

Revenue trend+10% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +5% a year.

Margin direction−9.0 points operating

Trailing-twelve-month operating margin, 7.1% now against 16.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BHC growing?

Bausch Health Companies Inc. has grown revenue 9.1% a year over three years and 5.1% a year over five.

+9.1%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +5.1%
Revenue growth, 5-year rate · +9.1% over three · growth has picked up over the last three years
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed

Details›